Antibodies as defensive enzymes

Springer Seminars in Immunopathology

Volumn 26, Issue 4, 2005, Pages 485-503

  Paul, Sudhir ^a   Nishiyama, Yasuhiro ^a   Planque, Stephanie ^a   Karle, Sangeeta ^a   Taguchi, Hiroaki ^a   Hanson, Carl ^b   Weksler, Marc E ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Abzymes; Autoimmune disease; Catalytic antibodies; HIV infection; Serine proteases

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ALZHEIMER DISEASE; ANTIBODY RESPONSE; ANTIBODY STRUCTURE; CATALYSIS; CHEMICAL REACTION KINETICS; COVALENT BOND; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNIZATION; INFECTION RESISTANCE; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES, CATALYTIC; BINDING SITES, ANTIBODY; ENZYMES; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNITY, NATURAL; MICE; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA;

EID: 16344377509     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-004-0191-1     Document Type: Review

References (85)

1. Abderhalden E (1912) Die Schutzfermente. Springer, Berlin
2. Ames PR, Alves J, Murat I, et al (1999) Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. Rheumatology 38:529
3. Bangale Y, Cavill D, Gordon T, et al (2002) Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice. Peptides 23:2251
4. Bangale Y, Karle S, Zhou Y-X, et al (2003) VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease. FASEB J 17:628
5. Berberian L, Goodglick L, Kipps TJ, et al (1993) Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261:1588
6. Bernoud-Hubac N, Roberts J (2002) Identification of oxidized derivatives of neuroketals. Biochemistry 41:11466
7. Biro A, Sarmay G, Rozsnyay Z, et al (1992) A trypsin-like serine protease activity on activated human B cells and various B cell lines. Eur J Immunol 22:2547
8. 2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J Neurobiol 26:325
9. + B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 10:364
10. Chavin SI, Franklin EC (1969) Studies on antigen-binding activity of macroglobulin antibody subunits and their enzymatic fragments. J Biol Chem 244:1345
11. Chen TY, Huang CC, Tsao CJ (1993) Hemostatic molecular markers in nephrotic syndrome. Am J Hematol 44:276
12. Crabb JW, O'Neil J, Miyagi M, et al (2002) Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Sci 11:831
13. Deichmann U, Muller-Hill B (1998) The fraud of Abderhalden's enzymes. Nature 393:109
14. DeMattos RB, Bales KR, Cummins DJ, et al (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 98:885
15. Dodel RC, Du Y, Depboylu C, et al (2004) Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry 75:1472
16. Erhan S, Greller LD (1974) Do immunoglobulins have proteolytic activity? Nature 251:353
17. Fersht A (1985) Enzyme structure and mechanism. Freeman, New York
18. Gao Q-S, Sun M, Rees A, et al (1995) Site-directed mutagenesis of proteolytic antibody light chain. J Mol Biol 253:658
19. Gaskin F, Finley J, Fang Q, et al (1993) Human antibodies reactive with beta-amyloid protein in Alzheimer's disease. J Exp Med 177:1181
20. Gololobov G, Sun M, Paul S (1999) Innate antibody catalysis. Mol Immunol 36:1215
21. Goodglick L, Zevit N, Neshat MS, et al (1995) Mapping the Ig superantigen-binding site of HIV-1 gp120. J Immunol 155:5151
22. Grabar P (1975) Hypothesis. Auto-antibodies and immunological theories: an analytical review. Clin Immunol Immunopathol 4:453
23. Hasegawa M, Fujimoto M, Poe JC, et al (2001) A CD19-dependent signaling pathway regulates autoimmunity in lyn-deficient mice. J Immunol 167:2469
24. Hasegawa M, Fujimoto M, Poe JC, et al (2001) CD19 can regulate B lymphocyte signal transduction independent of complement activation. J Immunol 167:3190
25. Hyman BT, Smith C, Buldyrev I, et al (2001) Autoantibodies to amyloid-beta and Alzheimer's disease. Ann Neurol 49:808
26. Inoue M, Hiratake J, Suzuki H, et al (2000) Identification of catalytic nucleophile of Escherichia coli gamma-glutamyltranspeptidase by gamma-monofluorophosphono derivative of glutamic acid: N-terminal thr-391 in small subunit is the nucleophile. Biochemistry 39:7764
27. Jeannin P, Lecoanet-Henchoz S, Delneste Y, et al (1998) Alpha-1 antitrypsin up-regulates human B cell differentiation selectively into IgE- and IgG4- secreting cells. Eur J Immunol 28:1815
28. Jia Y, Kappock TJ, Frick T, et al (2000) Lipases provide a new mechanistic model for polyhydroxybutyrate (PHB) synthases: characterization of the functional residues in Chromatium vinosum PHB synthase. Biochemistry 39:3927
29. Kalaga R, Li L, O'Dell J, et al (1995) Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J Immunol 155:2695
30. Karray S, Zouali M (1997) Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc Natl Acad Sci USA 94:1356
31. Kaul M, Lipton SA (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 96:8212
32. Kohen F, Kim JB, Linder HR, et al (1980) Monoclonal immunoglobulin G augments hydrolysis of an ester of the homologous hapten: An esterase-like activity of the antibody-containing site. FEBS Lett 111:427
33. Ku GS, Quigley JP, Sultzer BM (1981) Time-dependent inhibition of tuberculin-induced lymphocyte DNA synthesis by a serine protease inhibitor. J Immunol 126:2209
34. Ku GS, Quigley JP, Sultzer BM (1983) The inhibition of the mitogenic stimulation of B lymphocytes by a serine protease inhibitor: commitment to proliferation correlates with an enhanced expression of a cell-associated arginine-specific serine enzyme. J Immunol 131:2494
35. Kwong PD, Wyatt R, Robinson J, et al (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648
36. Lacroix-Desmazes S, Moreau A, Sooryanarayana, et al (1999) Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med 5:1044
37. Lefevre S, Debat H, Thomas D, et al (2001) A suicide-substrate mechanism for hydrolysis of beta-lactams by an anti-idiotypic catalytic antibody. FEBS Lett 489:25
38. Li L, Kaveri S, Tyutyulkova S, et al (1995) Catalytic activity of anti-thyroglobulin antibodies. J Immunol 154:3328
39. Liu R, McAllister C, Lyubchenko Y, et al (2004) Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity. Biochemistry 43:9999
40. Lucey MD, Newkirk MM, Neville C, et al (2000) Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. J Rheumatol 27:319
41. Lue LF, Walker DG (2002) Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide. J Neurosci Res 70:599
42. Matsuura K, Sinohara H (1996) Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginylglycinamide bond. Biol Chem 377:587
43. Matsuura K, Yamamoto K, Sinohara H (1994) Amidase activity of human Bence Jones proteins. Biochem Biophys Res Commun 204:57
44. Mitsuda Y, Hifumi E, Tsuruhata K, et al (2004) Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant. Biotechnol Bioeng 86:217
45. Mizuguchi J, Utsunomiya N, Nakanishi M, et al (1989) Differential sensitivity of anti-IgM-induced and NaF-induced inositol phospholipid metabolism to serine protease inhibitors in BAL17 B lymphoma cells. Biochem J 263:641
46. Morelock MM, Rothlein R, Bright SM, et al (1994) Isotype choice for chimeric antibodies affects binding properties. J Biol Chem 269:13048
47. Nath A, Hall E, Tuzova M, et al (2003) Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. Neuromolecular Med 3:29
48. Nevinsky GA, Buneva VN (2003) Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases. J Cell Mol Med 7:265
49. Nevinsky GA, Kit YYa, Semenov DV, et al (1998) Secretory immunoglobulin A from human milk catalyzes milk protein phosphorylation. Appl Biochem Biotechnol 75:77
50. Nishiyama Y, Bhatia G, Bangale Y, et al (2004) Towards selective covalent inactivation of pathogenic antibodies: a phosphonate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies. J Biol Chem 279:7877
51. O'Keefe TL, Williams GT, Batista FD, et al (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189:1307
52. Oleksyszyn J, Powers JC (1994) Amino acid and peptide phosphonate derivatives as specific inhibitors of serine peptidases. Methods Enzymol 244:423
53. Olshevsky U, Helseth E, Furman C, et al (1990) Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol 64:5701
54. Paul S (1996) Natural catalytic antibodies. Mol Biotechnol 5:197
55. Paul S, Karle S, Planque S, et al (2004) Naturally occurring proteolytic antibodies: selective IgM-catalyzed hydrolysis of HIV gp120. J Biol Chem 279:39611
56. L fragment. J Biol Chem 270:15257
57. Paul S, Planque S, Zhou Y-X, et al (2003) Specific HIV gp120 cleaving antibodies induced by covalently reactive analog of gp120. J Biol Chem 278:20429
58. Paul S, Tramontano A, Gololobov G, et al (2001) Phosphonate ester probes for proteolytic antibodies. J Biol Chem 276:28314
59. Paul S, Volle DJ, Beach CM, et al (1989) Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244:1158
60. Planque S, Bangale Y, Song X-T, et al (2004) Ontogeny of proteolytic immunity: IgM serine proteases. J Biol Chem 279:14024
61. Planque S, Taguchi H, Burr G, et al (2003) Broadly distributed chemical reactivity of natural antibodies expressed in coordination with specific antigen binding activity. J Biol Chem 278:20436
62. Pollard S, Meier W, Chow P, et al (1991) CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion. Proc Natl Acad Sci USA 88:11320
63. Rangan SK, Liu R, Brune D, et al (2003) Degradation of β-amyloid by proteolytic antibody light chains. Biochemistry 42:14328
64. Rao G, Philipp M (1991) Irreversible inhibition of a monoclonal antibody by a nitrophenyl ester. J Protein Chem 10:117
65. Raso V, Stollar BD (1975) The antibody-enzyme analogy. Comparison of enzymes and antibodies specific for phosphopyridoxyltyrosine. Biochemistry 14:591
66. Richieri SP, Bartholomew R, Aloia RC, et al (1998) Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine 16:119
67. Saveliev AN, Ivanen DR, Kulminskaya AA, et al (2003) Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol Lett 86:291
68. Shuster AM, Gololobov GV, Kvashuk OA, et al (1992) DNA hydrolyzing autoantibodies. Science 256:665
69. Sigurdsson EM, Knudsen E, Asuni A, et al (2004) An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives. J Neurosci 24:6277
70. Siliciano RF (1996) The role of CD4 in HIV envelope-mediated pathogenesis. Curr Top Microbiol Immunol 205:159
71. Sun M, Gao QS, Kirnarskiy L, et al (1997) Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain. J Mol Biol 271:374
72. Taguchi H, Burr G, Karle S, et al (2002) A mechanism-based probe for gp120-hydrolyzing antibodies. Bioorg Med Chem Lett 12:3167
73. Taguchi H, Planque S, Nishiyama Y, et al (2004) Catalytic hydrolysis of amyloid β-peptide (Aβ) by human antibodies. 9th International Conference on Alzheimer's Disease and Related Disorders, July 2004, Philadelphia, PA. Abstract P4-331
74. Taguchi H, Planque S, Nishiyama Y, et al (2004) IgM defense enzymes directed to amyloid β peptide. 9th International Conference on Alzheimer's Disease and Related Disorders. July 2004, Philadelphia, PA. Abstract P3-418
75. Townsley-Fuchs J, Kam L, Fairhurst R, et al (1996) Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission. J Clin Invest 98:1794
76. Tramontano A, Gololobov G, Paul S (2000) Proteolytic antibodies: origins, selection and induction. In: Paul S (ed) Chemical Immunology: catalytic antibodies, vol 77. Karger, Basel, pp 1-17
77. Tramontano A, Janda KD, Lerner RA (1986) Catalytic antibodies. Science 234:1566
78. Tyutyulkova S, Gao Q-S, Thompson A, et al (1996) Efficient vasoactive intestinal polypeptide hydrolyzing antibody light chains selected from an asthma patient by phage display. Biochim Biophys Acta 1316:217
79. Van Erp R, Gribnau TC, Sommeren AP van, et al (1991) Affinity of monoclonal antibodies. Interpretation of the positive cooperative nature of anti-hCG/hCG interactions. J Immunol Methods 140:235
80. Vocadlo DJ, Davies GJ, Laine R, et al (2001) Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate. Nature 412:835
81. Wagner J, Lerner RA, Barbas CF 3rd (1995) Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes. Science 270:1797
82. Walter J, Bode W (1983) The X-ray crystal structure analysis of the refined complex formed by bovine trypsin and p-amidinophenylpyruvate at 1.4 A resolution. Hoppe-Seyler's Z Physiol Chem 364:S949
83. Watson JN, Dookhun V, Borgford TJ, et al (2003) Mutagenesis of the conserved active-site tyrosine changes a retaining sialidase into an inverting sialidase. Biochemistry 42:12682
84. Weksler ME, Relkin N, Turkenich R, et al (2002) Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals. Exp Gerontol 37:943
85. Wentworth P, Jones LH, Wentworth AD, et al (2001) Antibody catalysis of the oxidation of water. Science 293:1806